Additionally, women who were not taking HRT (regardless of NAFLD status) had a higher likelihood of being overweight, obese, and insulin resistant compared to women who were taking HRT [61]. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.